论文部分内容阅读
宫颈癌是临床妇科中的一种常见恶性肿瘤,发病率仅次于乳腺癌位居妇科恶性肿瘤第二位,目前发病率呈不断上升的趋势~([1])。人乳头状瘤病毒(HPV)是宫颈癌发病的一个重要危险因素~([2]),因此大部分宫颈癌患者均合并HPV感染。本研究探讨奈达铂联合紫杉醇对HPV阳性宫颈癌患者术后辅助化疗的临床干预效果。
Cervical cancer is a common malignant tumor in clinical gynecology. Its incidence is second only to that of breast cancer, and its incidence is on the rise at present ([1]). Human papillomavirus (HPV) is an important risk factor for cervical cancer ~ ([2]), so most cervical cancer patients have HPV infection. This study was to investigate the clinical efficacy of nedaplatin combined with paclitaxel for postoperative adjuvant chemotherapy in patients with HPV-positive cervical cancer.